Advertisement

Index by Author

November 2000; 23 (11)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abe, T

    • Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure? Diabetes Care November 2000 23:1703; doi:10.2337/diacare.23.11.1703b

  2. Aiello, L P

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

  3. Anhalt, H

    • Are tumor necrosis factor-alpha receptor 2 levels associated with age? Diabetes Care November 2000 23:1713-1715; doi:10.2337/diacare.23.11.1713

  4. Aronoff, S

    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care November 2000 23:1605-1611; doi:10.2337/diacare.23.11.1605

B

  1. Balfour, J

    • Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care November 2000 23:1642-1647; doi:10.2337/diacare.23.11.1642

  2. Bell, R A

    • Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care November 2000 23:1630-1636; doi:10.2337/diacare.23.11.1630

  3. Benhamou, P Y

    • Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care November 2000 23:1679-1685; doi:10.2337/diacare.23.11.1679

  4. Bergenstal, R

    • A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care November 2000 23:1666-1671; doi:10.2337/diacare.23.11.1666

  5. Bergholm, R

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

  6. Bloomgarden, Z T

    • American Diabetes Association 60th Scientific Sessions, 2000: diabetes and pregnancy. Diabetes Care November 2000 23:1699-1702; doi:10.2337/diacare.23.11.1699

  7. Boizel, R

    • Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care November 2000 23:1679-1685; doi:10.2337/diacare.23.11.1679

  8. Braithwaite, S

    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care November 2000 23:1605-1611; doi:10.2337/diacare.23.11.1605

  9. Brancati, F L

    • Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care November 2000 23:1642-1647; doi:10.2337/diacare.23.11.1642

  10. Brown, J B

    • Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care November 2000 23:1654-1659; doi:10.2337/diacare.23.11.1654

  11. Bursell, S E

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

C

  1. Carreras, G

    • Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients? Diabetes Care November 2000 23:1715-1716; doi:10.2337/diacare.23.11.1715a

  2. Caspersen, C J

    • Moderate-intensity physical activity and fasting insulin levels in women. Diabetes Care November 2000 23:1712-1713; doi:10.2337/diacare.23.11.1712

  3. Chen, Y

    • Prevalence of diabetes in Canadian adults aged 40 years or older. Diabetes Care November 2000 23:1704-1705; doi:10.2337/diacare.23.11.1704

  4. Chiang, M T

    • Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care November 2000 23:1703-1704; doi:10.2337/diacare.23.11.1703a

  5. Clermont, A C

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

  6. Clinkingbeard, C

    • Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care November 2000 23:1660-1665; doi:10.2337/diacare.23.11.1660

  7. Cohen, R M

    • Implications of linking pharmacy and laboratory data to assess diabetes care. Diabetes Care November 2000 23:1603-1604; doi:10.2337/diacare.23.11.1603

  8. Cotta, L

    • Relevance of the treatment facility for disease-related knowledge of diabetic patients. Diabetes Care November 2000 23:1708-1709; doi:10.2337/diacare.23.11.1708

D

  1. D'Agostino, R B, Jr

    • Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care November 2000 23:1630-1636; doi:10.2337/diacare.23.11.1630

  2. Daneman, D

    • School attendance of children with type 1 diabetes. Diabetes Care November 2000 23:1706-1707; doi:10.2337/diacare.23.11.1706

  3. Davies, R

    • Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study. Diabetes Care November 2000 23:1612-1618; doi:10.2337/diacare.23.11.1612

  4. de Leiva, A

    • Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients? Diabetes Care November 2000 23:1715-1716; doi:10.2337/diacare.23.11.1715a

  5. Dewitte, K

    • Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line". Diabetes Care November 2000 23:1711-1712; doi:10.2337/diacare.23.11.1711

  6. Donley, D

    • A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care November 2000 23:1666-1671; doi:10.2337/diacare.23.11.1666

E

  1. Egan, J W

    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care November 2000 23:1605-1611; doi:10.2337/diacare.23.11.1605

  2. Erkkilä, H

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

F

  1. Feng, D

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

  2. Fierens, C

    • Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line". Diabetes Care November 2000 23:1711-1712; doi:10.2337/diacare.23.11.1711

  3. Fliege, H

    • Relevance of the treatment facility for disease-related knowledge of diabetic patients. Diabetes Care November 2000 23:1708-1709; doi:10.2337/diacare.23.11.1708

  4. Foley, J

    • Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care November 2000 23:1660-1665; doi:10.2337/diacare.23.11.1660

  5. Foulon, T

    • Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care November 2000 23:1679-1685; doi:10.2337/diacare.23.11.1679

  6. Fox, C

    • Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study. Diabetes Care November 2000 23:1612-1618; doi:10.2337/diacare.23.11.1612

  7. Fulton, J E

    • Moderate-intensity physical activity and fasting insulin levels in women. Diabetes Care November 2000 23:1712-1713; doi:10.2337/diacare.23.11.1712

G

  1. Gatlin, M

    • Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care November 2000 23:1660-1665; doi:10.2337/diacare.23.11.1660

  2. Glaab, L

    • School attendance of children with type 1 diabetes. Diabetes Care November 2000 23:1706-1707; doi:10.2337/diacare.23.11.1706

  3. Glauber, H S

    • Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care November 2000 23:1654-1659; doi:10.2337/diacare.23.11.1654

  4. Guralnik, J M

    • Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care November 2000 23:1642-1647; doi:10.2337/diacare.23.11.1642

H

  1. Haddow, J E

    • Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis. Diabetes Care November 2000 23:1705-1706; doi:10.2337/diacare.23.11.1705

  2. Haffner, S M

    • Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care November 2000 23:1630-1636; doi:10.2337/diacare.23.11.1630

  3. Halimi, S

    • Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care November 2000 23:1679-1685; doi:10.2337/diacare.23.11.1679

  4. Hallé, J P

    • A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care November 2000 23:1666-1671; doi:10.2337/diacare.23.11.1666

  5. Hayakawa, T

    • Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure? Diabetes Care November 2000 23:1703; doi:10.2337/diacare.23.11.1703b

  6. Hermos, R J

    • Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis. Diabetes Care November 2000 23:1705-1706; doi:10.2337/diacare.23.11.1705

  7. Hildebrandt, M

    • Relevance of the treatment facility for disease-related knowledge of diabetic patients. Diabetes Care November 2000 23:1708-1709; doi:10.2337/diacare.23.11.1708

  8. Hoogwerf, B J

    • Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care November 2000 23:1648-1653; doi:10.2337/diacare.23.11.1648

  9. Horton, E S

    • Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care November 2000 23:1660-1665; doi:10.2337/diacare.23.11.1660

K

  1. Kiess, W

    • "Lady-like": is there a latent autoimmune diabetes in the young? Diabetes Care November 2000 23:1707-1708; doi:10.2337/diacare.23.11.1707

  2. King, G L

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

  3. Klaff, L

    • A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care November 2000 23:1666-1671; doi:10.2337/diacare.23.11.1666

  4. Klapp, B F

    • Relevance of the treatment facility for disease-related knowledge of diabetic patients. Diabetes Care November 2000 23:1708-1709; doi:10.2337/diacare.23.11.1708

L

  1. Laffel, L

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

  2. Laporte, F

    • Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care November 2000 23:1679-1685; doi:10.2337/diacare.23.11.1679

  3. Lardy, B

    • Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care November 2000 23:1679-1685; doi:10.2337/diacare.23.11.1679

  4. Larson, C A

    • Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis. Diabetes Care November 2000 23:1705-1706; doi:10.2337/diacare.23.11.1705

  5. Lee, W J

    • Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care November 2000 23:1703-1704; doi:10.2337/diacare.23.11.1703a

  6. Leveille, S G

    • Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care November 2000 23:1642-1647; doi:10.2337/diacare.23.11.1642

  7. Lipinska, I

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

  8. Lithner, F

    • Venlafaxine in treatment of severe painful peripheral diabetic neuropathy. Diabetes Care November 2000 23:1710-1711; doi:10.2337/diacare.23.11.1710

  9. Lohmann, T

    • "Lady-like": is there a latent autoimmune diabetes in the young? Diabetes Care November 2000 23:1707-1708; doi:10.2337/diacare.23.11.1707

M

  1. Mäkimattila, S

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

  2. Mallows, S

    • Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care November 2000 23:1660-1665; doi:10.2337/diacare.23.11.1660

  3. Mäntysaari, M

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

  4. Martin, M A

    • Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care November 2000 23:1630-1636; doi:10.2337/diacare.23.11.1630

  5. Mathisen, A L

    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care November 2000 23:1605-1611; doi:10.2337/diacare.23.11.1605

  6. Matz, R

    • Hypoglycemia, seizures, and pulmonary edema. Diabetes Care November 2000 23:1715; doi:10.2337/diacare.23.11.1715b

  7. Mauricio, D

    • Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients? Diabetes Care November 2000 23:1715-1716; doi:10.2337/diacare.23.11.1715a

  8. Mayer-Davis, E J

    • Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care November 2000 23:1630-1636; doi:10.2337/diacare.23.11.1630

  9. Mecca, T

    • A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care November 2000 23:1666-1671; doi:10.2337/diacare.23.11.1666

  10. Mitchell, M L

    • Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis. Diabetes Care November 2000 23:1705-1706; doi:10.2337/diacare.23.11.1705

N

  1. Nagai, Y

    • Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure? Diabetes Care November 2000 23:1703; doi:10.2337/diacare.23.11.1703b

  2. Nichols, G A

    • Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care November 2000 23:1654-1659; doi:10.2337/diacare.23.11.1654

  3. Nietzschmann, U

    • "Lady-like": is there a latent autoimmune diabetes in the young? Diabetes Care November 2000 23:1707-1708; doi:10.2337/diacare.23.11.1707

  4. Niskanen, L K

    • Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care November 2000 23:1672-1678; doi:10.2337/diacare.23.11.1672

  5. Nomura, G

    • Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure? Diabetes Care November 2000 23:1703; doi:10.2337/diacare.23.11.1703b

P

  1. Palomaki, G E

    • Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis. Diabetes Care November 2000 23:1705-1706; doi:10.2337/diacare.23.11.1705

  2. Park, E M

    • Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care November 2000 23:1648-1653; doi:10.2337/diacare.23.11.1648

  3. Pashkow, F J

    • Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care November 2000 23:1648-1653; doi:10.2337/diacare.23.11.1648

  4. Paz-Priel, I

    • Are tumor necrosis factor-alpha receptor 2 levels associated with age? Diabetes Care November 2000 23:1713-1715; doi:10.2337/diacare.23.11.1713

  5. Pearce, G L

    • Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care November 2000 23:1648-1653; doi:10.2337/diacare.23.11.1648

  6. Pérez, A

    • Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients? Diabetes Care November 2000 23:1715-1716; doi:10.2337/diacare.23.11.1715a

  7. Perlman, K

    • School attendance of children with type 1 diabetes. Diabetes Care November 2000 23:1706-1707; doi:10.2337/diacare.23.11.1706

R

  1. Raskin, P

    • A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care November 2000 23:1666-1671; doi:10.2337/diacare.23.11.1666

  2. Resnick, H E

    • Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care November 2000 23:1642-1647; doi:10.2337/diacare.23.11.1642

  3. Rose, M

    • Relevance of the treatment facility for disease-related knowledge of diabetic patients. Diabetes Care November 2000 23:1708-1709; doi:10.2337/diacare.23.11.1708

  4. Rosenblatt, S

    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care November 2000 23:1605-1611; doi:10.2337/diacare.23.11.1605

S

  1. Saar, P

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

  2. Sampson, M

    • Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study. Diabetes Care November 2000 23:1612-1618; doi:10.2337/diacare.23.11.1612

  3. Schirop, T

    • Relevance of the treatment facility for disease-related knowledge of diabetic patients. Diabetes Care November 2000 23:1708-1709; doi:10.2337/diacare.23.11.1708

  4. Schlenzka, A

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

  5. Schneider, R L

    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care November 2000 23:1605-1611; doi:10.2337/diacare.23.11.1605

  6. Schwartz, A V

    • Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care November 2000 23:1642-1647; doi:10.2337/diacare.23.11.1642

  7. Seidlitz, B

    • Relevance of the treatment facility for disease-related knowledge of diabetic patients. Diabetes Care November 2000 23:1708-1709; doi:10.2337/diacare.23.11.1708

  8. Shen, S

    • Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care November 2000 23:1660-1665; doi:10.2337/diacare.23.11.1660

  9. Sheu, W H

    • Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care November 2000 23:1703-1704; doi:10.2337/diacare.23.11.1703a

  10. Snyder, J W

    • Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes. Diabetes Care November 2000 23:1637-1641; doi:10.2337/diacare.23.11.1637

  11. Sprecher, D L

    • Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care November 2000 23:1648-1653; doi:10.2337/diacare.23.11.1648

  12. Stöckl, D

    • Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line". Diabetes Care November 2000 23:1711-1712; doi:10.2337/diacare.23.11.1711

  13. Summanen, P

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

T

  1. Taha, W

    • Are tumor necrosis factor-alpha receptor 2 levels associated with age? Diabetes Care November 2000 23:1713-1715; doi:10.2337/diacare.23.11.1713

  2. Tai, T S

    • Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care November 2000 23:1703-1704; doi:10.2337/diacare.23.11.1703a

  3. Tang, M

    • Prevalence of diabetes in Canadian adults aged 40 years or older. Diabetes Care November 2000 23:1704-1705; doi:10.2337/diacare.23.11.1704

  4. Taylor, R

    • Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study. Diabetes Care November 2000 23:1612-1618; doi:10.2337/diacare.23.11.1612

  5. Teräsvirta, M E

    • Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care November 2000 23:1672-1678; doi:10.2337/diacare.23.11.1672

  6. Thienpont, L M

    • Evaluating clinical accuracy of systems for self-monitoring of blood glucose by error grid analysis: comment on constructing the "upper A-line". Diabetes Care November 2000 23:1711-1712; doi:10.2337/diacare.23.11.1711

  7. Tofler, G H

    • von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care November 2000 23:1694-1698; doi:10.2337/diacare.23.11.1694

U

  1. Uusitupa, M I

    • Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care November 2000 23:1672-1678; doi:10.2337/diacare.23.11.1672

V

  1. Vetiska, J

    • School attendance of children with type 1 diabetes. Diabetes Care November 2000 23:1706-1707; doi:10.2337/diacare.23.11.1706

  2. Vinik, A I

    • Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care November 2000 23:1642-1647; doi:10.2337/diacare.23.11.1642

  3. Voutilainen-Kaunisto, R M

    • Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance. Diabetes Care November 2000 23:1672-1678; doi:10.2337/diacare.23.11.1672

W

  1. Weaver, J U

    • Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study. Diabetes Care November 2000 23:1612-1618; doi:10.2337/diacare.23.11.1612

  2. Wetzler, H P

    • Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes. Diabetes Care November 2000 23:1637-1641; doi:10.2337/diacare.23.11.1637

  3. Wood, L

    • Appropriate insulin regimes for type 2 diabetes: a multicenter randomized crossover study. Diabetes Care November 2000 23:1612-1618; doi:10.2337/diacare.23.11.1612

Y

  1. Yao, H T

    • Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care November 2000 23:1703-1704; doi:10.2337/diacare.23.11.1703a

  2. Yki-Järvinen, H

    • Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes. Diabetes Care November 2000 23:1686-1693; doi:10.2337/diacare.23.11.1686

Z

  1. Zack, M M

    • Moderate-intensity physical activity and fasting insulin levels in women. Diabetes Care November 2000 23:1712-1713; doi:10.2337/diacare.23.11.1712

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement